openPR Logo
Press release

Long-Term investors in shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) should contact the Shareholders Foundation in connection with possible Wrongdoing by certain directors

An investigation on behalf of current long term investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) shares.

An investigation on behalf of current long term investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) shares.

An investigation was announced for current long-term investors in shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) concerning potential breaches of fiduciary duties by certain directors and officers of Anavex Life Sciences Corp.

Investors who are current long term investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: AVXL stocks follows a lawsuit filed against Anavex Life Sciences Corp. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: AVXL stocks, concerns whether certain Anavex Life Sciences Corp. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that, the Defendants violated Section 10(b) of the 1934 Act by failing to disclose pertinent information relevant to the Company or, alternatively, providing information about the Company which was misleading or deceptive.

Those who purchased shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Long-Term investors in shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) should contact the Shareholders Foundation in connection with possible Wrongdoing by certain directors here

News-ID: 3826245 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Baxter International Inc. (NYSE: BAX)
Lawsuit filed for Investors who lost money with shares of Baxter International I …
An investor, who purchased shares of Baxter International Inc. (NYSE: BAX), filed a lawsuit over alleged violations of Federal Securities Laws by Baxter International Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Baxter International Inc. (NYSE: BAX) have certain options and for certain investors are short and strict deadlines running. Deadline: September 11, 2023. NYSE: BAX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Long-Term Investors in shares of Charter Communications, Inc. (NASDAQ: CHTR)
Investigation announced for Long-Term Investors in shares of Charter Communicati …
An investigation was announced for current long-term investors in shares of Charter Communications, Inc. (NASDAQ: CHTR) concerning potential breaches of fiduciary duties by certain directors of Charter Communications, Inc. Investors who are current long term investors in Charter Communications, Inc. (NASDAQ: CHTR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors
V.F. Corporation (NYSE: VFC) Investor Notice: Deadline in Lawsuit on November 12, 2025
V.F. Corporation (NYSE: VFC) Investor Notice: Deadline in Lawsuit on November 12 …
A deadline is coming up on November 12, 2025 in the lawsuit filed for certain investors of V.F. Corporation (NYSE: VFC) over alleged securities laws violations by V.F. Corporation. Investors who purchased shares of V.F. Corporation (NYSE: VFC) have certain options and there are strict and short deadlines running. Deadline: November 12, 2025. V.F. Corporation (NYSE: VFC) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According
Fluor Corporation (NYSE: FLR) Investor Alert: Deadline in Lawsuit on November 14, 2025
Fluor Corporation (NYSE: FLR) Investor Alert: Deadline in Lawsuit on November 14 …
A deadline is coming up on November 14, 2025 in the lawsuit filed for certain investors of Fluor Corporation (NYSE: FLR) over alleged securities laws violations by Fluor Corporation. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and there are strict and short deadlines running. Deadline: November 14, 2025. NYSE: FLR) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the

All 5 Releases


More Releases for Anavex

Blarcamesine Market Key Business Strategies, Demand & Forecast - 2032| Anavex Li …
The Blarcamesine market is estimated to be valued at USD 822.9 Mn in 2025 and is expected to reach USD 1,082.8 Mn by 2032, growing at a compound annual growth rate CAGR of 5.0% from 2025 to 2032. ➤ Coherent Market Insights has been added with a new research study titled Blarcamesine Market 2025 analysis by Market Trends (Drivers, Constraints, Opportunities, Risks, Challenges, and Investment Opportunities), Size, Share, and Outlook." ➤ Request
Blarcamesine Market Is Booming So Rapidly 2025-2032 -Anavex Life Sciences
Global blarcamesin market will be valued at US$ 822.9 Mn in 2025 and is expected to reach US$ 1,082.8 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.0% from 2025 to 2032. The qualitative latest Research report (2025-2032) on the Blarcamesine Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR
Global Blarcamesine Market Generated Opportunities, Future Scope 2025-2032 | Ana …
Global blarcamesin market will be valued at US$ 822.9 Mn in 2025 and is expected to reach US$ 1,082.8 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.0% from 2025 to 2032. The latest report (2025-2032) on the Global Blarcamesine Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using
Global Blarcamesine Market Projected for Significant Expansion by 2032 - Anavex …
Global blarcamesin market will be valued at US$ 822.9 Mn in 2025 and is expected to reach US$ 1,082.8 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.0% from 2025 to 2032. Latest Qualitative Research Report on the Global Blarcamesine Market Size 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive
Blarcamesine Market Set to Witness Substantial Growth | Innovations & Industry O …
The global Blarcamesine Market is expected to grow at 3.8% CAGR from 2025 to 2032. The latest Research report published by CMI with the title "An Increase in Demand and Opportunities for Global Blarcamesine Market 2025" provides a sorted image of the Blarcamesine Market industry by analysis of research and information collected from various sources that have the ability to help the decision-makers in the worldwide market to play a significant
Blarcamesine Market Generated Opportunities, Future Scope 2024-2031 | Anavex Lif …
Blarcamesine Market Trends Overview 2024-2031: Global blarcamesin market will be valued at US$ 822.2 Mn in 2026 and is expected to reach US$ 992.4 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2026 to 2031. A new Report by Coherent Market Insights, titled "Blarcamesine Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Blarcamesine